Shortened treatment regimens versus the standard regimen for drug‐sensitive pulmonary tuberculosis

This review (5 RCTs; n=5825) found the evidence to date does not support use of shortened anti-TB regimens. Four-month regimens that replace ethambutol with moxifloxacin or gatifloxacin, or isoniazid with moxifloxacin, increase relapse substantially.


Cochrane Database of Systematic Reviews